Barrow Neurological Foundation

Barrow Neurological Foundation

Barrow Neurological Foundation was established in 1960 to support Barrow Neurological Institute, a clinical and research center that operates on the Dignignity Health St. Joseph's Hospital and Medical Center campus in Phoenix. The foundation is led by Board Chair Mitchel Sayare, co-founder of ImmunoGen, and funnels contributions exclusively to the specialty neuroscience work overseen by Institute President and CEO Michael T. Lawton, MD. The foundation's deployment model is binary: it raises funds and passes them through at a stated 100% rate to fund research, education, and patient care within the institute. Its investment portfolio anchors the gift pipeline rather than competing with external managers. Donations have supported the Ivy Brain Tumor Center, a clinical trials engine backed by the Ben and Catherine Ivy Foundation, as well as the Muhammad Ali Parkinson Center, which counts the Bob & Renee Parsons Foundation as a significant funder. Real estate holdings linked to the initiative include the Neuroplex and the Barrow Neuro Analytics Center, both in Phoenix. While the foundation does not publicly disclose team headcount, its board includes trustees with affiliations that reach beyond medicine: David Van Denburgh via the Young Presidents Organization and Jim Wentworth via the NAIOP Arizona commercial real estate network. These connections supplement the core relationships with CommonSpirit Health and Arizona State University, where several board members also hold leadership roles. The foundation's structure is tightly tied to the institute it serves, making it less an allocator and more a dedicated funding conduit. Structurally, the foundation stands apart from diversified endowments by operating with a single-sector mandate. It does not make for-profit venture investments or partner with external general partners. Instead, it collects assets — from a commercial real estate portfolio to an art collection — and liquidates or holds them solely to support the Barrow Neurological Institute's clinical and scientific objectives. This arrangement mirrors the hyper-concentrated model of disease-specific foundations but with a rare institutional anchor in a top-10 US neurology and neurosurgery center.